{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T18:54:01Z","timestamp":1768244041313,"version":"3.49.0"},"reference-count":57,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["NIHR206602"],"award-info":[{"award-number":["NIHR206602"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,11,24]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Visual Hallucinations (VHs) (seeing things that others do not, or visions) are a common feature of psychosis, causing significant distress and disability. Services rarely ask about these important experiences, and crucially there are no proven beneficial psychological treatments. There are at least two key challenges faced when treating VHs. First, people report not knowing why they see things others don\u2019t, which leads them to feel alone and different from others. Second, they feel they cannot trust their own eyes to tell what is real or not, which can lead to fears they will be hurt or harmed by the VH, or even if they know the experience is not real, they may fear that they are losing their mind, or that they are not able to control or manage their experiences. For these reasons, they may struggle to put skills and strategies into practice when in the presence of the VH. Consequently, we have developed a novel treatment that addresses these core issues. First, we have a psycho-education and coping strategies package called Visual Unusual Sensory Experiences (VUSE) that uses the best aspects of digital technology (animations, videos) to explain why people have VHs and provides normalising information to help the person to feel less alone. It introduces coping strategies that are then tested in Virtual Reality sessions (VR for Visions VRV) where a representation of the visual experience is provided, enabling the person to safely develop skills and gain a sense of mastery and empowerment. We now plan to test this approach in a proof-of-concept study to help determine if this will help people use these skills in the real world and so help reduce distress, improve functioning and quality of life. We will address uncertainties in the feasibility of developing and delivering this treatment and inform its future use in a larger trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The study is a single arm feasibility trial (n=16) evaluating VUSE+VRV\u2009and treatment as usual. The study is recruiting people with psychosis and distressing VHs in one NHS Trust and uses independent but non-blind research assistants to undertake assessments before, during and after treatment (at baseline, 6, 12\u2009week) and at follow-up (16 weeks). Quantitative information on recruitment rates, adherence and completion of outcome assessments (VHs, other psychiatric symptoms, quality of life and perceived recovery) will be collected. Qualitative interviews will capture service-users\u2019 experience of therapy. Analyses will focus on feasibility outcomes and provide initial estimates of intervention effects. Thematic analysis of the qualitative interviews will assess the acceptability of the intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial has received NHS Ethical and Health Research Authority approval (25\/EM\/0077). Informed consent will be obtained from all participants. Findings will be disseminated directly to participants, and services as well as through open access peer-reviewed publication(s).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN11350954\">ISRCTN11350954<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-107535","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:31:37Z","timestamp":1768231897000},"page":"e107535","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Virtual reality for visions (VRV): a proof-of-concept study examining the development of a new treatment for distressing visual hallucinations in people with psychosis"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"isrctn11350954","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3765-9998","authenticated-orcid":false,"given":"Robert","family":"Dudley","sequence":"first","affiliation":[{"name":"University of York, York, UK"},{"name":"Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Sargeant","sequence":"additional","affiliation":[{"name":"The Open University, Milton Keynes, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Gibbs","sequence":"additional","affiliation":[{"name":"Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Prentice","sequence":"additional","affiliation":[{"name":"Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"McCartney","sequence":"additional","affiliation":[{"name":"Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Aynsworth","sequence":"additional","affiliation":[{"name":"University of York, York, UK"},{"name":"Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morag","family":"Maskey","sequence":"additional","affiliation":[{"name":"Northern Design Centre, XR therapeutics, Gateshead, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Skeggs","sequence":"additional","affiliation":[{"name":"Royal Derby Hospital, Derby, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"2026011207304154000_16.1.e107535.1","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1093\/schbul\/sbu036","article-title":"Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease","volume":"40 Suppl 4","author":"Waters","year":"2014","journal-title":"Schizophr Bull"},{"key":"2026011207304154000_16.1.e107535.2","unstructured":"Allen S , Jones C . What is the prevalence of visual hallucinations in a first-episode psychosis population? a systematic review and meta-analysis of the literature. n.d. Available: https:\/\/academic.oup.com\/schizbullopen\/advance-article\/doi\/10.1093\/schizbullopen\/sgad002\/7008614"},{"key":"2026011207304154000_16.1.e107535.3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/papt.12553","article-title":"Visual hallucinations in psychosis: What do people actually see?","volume":"98","author":"Aynsworth","year":"2025","journal-title":"Psychol Psychother"},{"key":"2026011207304154000_16.1.e107535.4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/10398562211038909","article-title":"Visual hallucinations in psychiatry - what aren\u2019t we seeing?","volume":"30","author":"Ayalde","year":"2022","journal-title":"Australas Psychiatry"},{"key":"2026011207304154000_16.1.e107535.5","doi-asserted-by":"crossref","DOI":"10.1038\/s41537-024-00450-8","article-title":"The relationship between visual hallucinations, functioning, and suicidality over the course of illness: a 10-year follow-up study in first-episode psychosis","volume":"10","author":"Kreis","year":"2024","journal-title":"Schizophrenia (Heidelb)"},{"key":"2026011207304154000_16.1.e107535.6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13546805.2021.1941832","article-title":"Imagine that: cholinesterase inhibitor treatment of complex visual hallucinations of unknown aetiology","volume":"26","author":"Salih","year":"2021","journal-title":"Cogn Neuropsychiatry"},{"key":"2026011207304154000_16.1.e107535.7","doi-asserted-by":"publisher","DOI":"10.1076\/neur.9.5.436.16557"},{"key":"2026011207304154000_16.1.e107535.8","doi-asserted-by":"crossref","unstructured":"Silverstein SM , Lai A . The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update. Front Psychiatry 2021;12. doi:10.3389\/fpsyt.2021.684720","DOI":"10.3389\/fpsyt.2021.684720"},{"key":"2026011207304154000_16.1.e107535.9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1017\/S135246581100035X","article-title":"Brief cognitive behavioural therapy for hallucinations: can it help people who decide not to take antipsychotic medication? A case report","volume":"40","author":"Hutton","year":"2012","journal-title":"Behav Cogn Psychother"},{"key":"2026011207304154000_16.1.e107535.10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S1352465812001130","article-title":"A graded exposure intervention for distressing visual hallucinations in schizophrenia","volume":"41","author":"O\u2019Brien","year":"2013","journal-title":"Behav Cogn Psychother"},{"key":"2026011207304154000_16.1.e107535.11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cpr.2017.05.001","article-title":"Measures of visual hallucinations: Review and recommendations","volume":"57","author":"Aynsworth","year":"2017","journal-title":"Clin Psychol Rev"},{"key":"2026011207304154000_16.1.e107535.12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cpp.1962","article-title":"Is Seeing Believing? The Process of Change During Cognitive\u2013behavioural Therapy for Distressing Visual Hallucinations","volume":"23","author":"Wilson","year":"2016","journal-title":"Clin Psychology and Psychoth"},{"key":"2026011207304154000_16.1.e107535.13","doi-asserted-by":"crossref","unstructured":"Thomson C , Wilson R , Collerton D , et al . Cognitive behavioural therapy for visual hallucinations: an investigation using a single-case experimental design. tCBT 2017;10. doi:10.1017\/S1754470X17000174","DOI":"10.1017\/S1754470X17000174"},{"key":"2026011207304154000_16.1.e107535.14","doi-asserted-by":"crossref","DOI":"10.1002\/cpp.2993","article-title":"Imagery-Focused Therapy for Visual Hallucinations: A Case Series","volume":"31","author":"Paulik","year":"2024","journal-title":"Clin Psychol Psychother"},{"key":"2026011207304154000_16.1.e107535.15","doi-asserted-by":"crossref","unstructured":"Skivington K , Matthews L , Simpson SA , et al . A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ 2021;n2061. doi:10.1136\/bmj.n2061","DOI":"10.1136\/bmj.n2061"},{"key":"2026011207304154000_16.1.e107535.16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.schres.2019.07.016","article-title":"Treatable clinical intervention targets for patients with schizophrenia","volume":"211","author":"Freeman","year":"2019","journal-title":"Schizophr Res"},{"key":"2026011207304154000_16.1.e107535.17","doi-asserted-by":"crossref","first-page":"116229","DOI":"10.1016\/j.psychres.2024.116229","article-title":"Hallucinations across sensory domains in people with post-traumatic stress disorder and psychosis","volume":"342","author":"Dudley","year":"2024","journal-title":"Psychiatry Res"},{"key":"2026011207304154000_16.1.e107535.18","doi-asserted-by":"publisher","DOI":"10.1348\/014466504x19451"},{"key":"2026011207304154000_16.1.e107535.19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/papt.12440","article-title":"What is the frequency and nature of visual hallucinations in non-clinical participants?","volume":"96","author":"Aynsworth","year":"2023","journal-title":"Psychol Psychother"},{"key":"2026011207304154000_16.1.e107535.20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/17522439.2012.699543","article-title":"Clinical characteristics of disclosed visual hallucinations in users of an Early Intervention in Psychosis Service","volume":"5","author":"Dudley","year":"2013","journal-title":"Psychosis"},{"key":"2026011207304154000_16.1.e107535.21","doi-asserted-by":"crossref","first-page":"114988","DOI":"10.1016\/j.psychres.2022.114988","article-title":"Prevalence and nature of multi-sensory and multi-modal hallucinations in people with first episode psychosis","volume":"319","author":"Dudley","year":"2023","journal-title":"Psychiatry Res"},{"key":"2026011207304154000_16.1.e107535.22","doi-asserted-by":"crossref","first-page":"115091","DOI":"10.1016\/j.psychres.2023.115091","article-title":"Prevalence of multisensory hallucinations in people at risk of transition to psychosis","volume":"322","author":"Dudley","year":"2023","journal-title":"Psychiatry Res"},{"key":"2026011207304154000_16.1.e107535.23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/schbul\/sbab104","article-title":"Sleep Disturbance in Individuals at Clinical High Risk for Psychosis","volume":"48","author":"Zaks","year":"2022","journal-title":"Schizophr Bull"},{"key":"2026011207304154000_16.1.e107535.24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1192\/bjp.2019.266","article-title":"Association between childhood trauma and multimodal early-onset hallucinations","volume":"216","author":"Medjkane","year":"2020","journal-title":"Br J Psychiatry"},{"key":"2026011207304154000_16.1.e107535.25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brat.2017.07.012","article-title":"Reality monitoring performance and the role of visual imagery in visual hallucinations","volume":"97","author":"Aynsworth","year":"2017","journal-title":"Behav Res Ther"},{"key":"2026011207304154000_16.1.e107535.26","unstructured":"Peters E , Besso L , Tsang WF , et al . Adapting the psychotic symptom rating scales (PSYRATS-Voices) to assess hallucinations in other modalities."},{"key":"2026011207304154000_16.1.e107535.27","unstructured":"Aynsworth C , Loe A , Humpston C , et al . Validation of the Hamilton Program for Schizophrenia Voices Questionnaire Adapted for Use with Visions. Oxford Health NHS Foundation Trust,"},{"key":"2026011207304154000_16.1.e107535.28","doi-asserted-by":"publisher","DOI":"10.1017\/S1352465804001626"},{"key":"2026011207304154000_16.1.e107535.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2014.04.006"},{"key":"2026011207304154000_16.1.e107535.30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061827","article-title":"Managing Unusual Sensory Experiences in People with First-Episode Psychosis (MUSE FEP): a study protocol for a single-blind parallel-group randomised controlled feasibility trial","volume":"12","author":"Dudley","year":"2022","journal-title":"BMJ Open"},{"key":"2026011207304154000_16.1.e107535.31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jpsychires.2024.04.031","article-title":"Effects of a novel, brief psychological therapy (Managing Unusual Sensory Experiences) for hallucinations in first episode psychosis (MUSE FEP): Findings from an exploratory randomised controlled trial","volume":"174","author":"Dudley","year":"2024","journal-title":"J Psychiatr Res"},{"key":"2026011207304154000_16.1.e107535.32","doi-asserted-by":"crossref","first-page":"116564","DOI":"10.1016\/j.psychres.2025.116564","article-title":"Managing unusual sensory experiences in at-risk mental state for psychosis in England: A parallel group, single-blind, randomised controlled feasibility trial","volume":"351","author":"Dodgson","year":"2025","journal-title":"Psychiatry Res"},{"key":"2026011207304154000_16.1.e107535.33","doi-asserted-by":"crossref","first-page":"114338","DOI":"10.1016\/j.psychres.2021.114338","article-title":"Virtual reality-based interventions for patients with paranoia: A systematic review","volume":"307","author":"Monaghesh","year":"2022","journal-title":"Psychiatry Res"},{"key":"2026011207304154000_16.1.e107535.34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S2215-0366(22)00060-8","article-title":"Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses","volume":"9","author":"Freeman","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"2026011207304154000_16.1.e107535.35","doi-asserted-by":"crossref","DOI":"10.1038\/s41537-021-00139-2","article-title":"One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia","volume":"7","author":"Dellazizzo","year":"2021","journal-title":"NPJ Schizophr"},{"key":"2026011207304154000_16.1.e107535.36","doi-asserted-by":"crossref","unstructured":"Glenth\u00f8j L , Smith L , Vernal D , et al . Virtual reality-assisted therapy targeting persistent auditory verbal hallucinations in patients diagnosed with schizophrenia spectrum disorders: the challenge single-blind, randomized clinical trial. In Review [Preprint] 2024. doi:10.21203\/rs.3.rs-5180922\/v1","DOI":"10.21203\/rs.3.rs-5180922\/v1"},{"key":"2026011207304154000_16.1.e107535.37","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1965"},{"key":"2026011207304154000_16.1.e107535.38","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291799008661"},{"key":"2026011207304154000_16.1.e107535.39","first-page":"73","article-title":"Quantifying self-reports of auditory verbal hallucinations in persons with psychosis","volume":"39","author":"Van Lieshout","year":"2007","journal-title":"Canadian Journal of Behavioural Science \/ Revue Canadienne Des Sciences Du Comportement"},{"key":"2026011207304154000_16.1.e107535.40","unstructured":"Mitchell CAA , Maybery MT , Russell-Smith SN , et al . Multi-modality unusual sensory experiences questionnaire (MUSEQ)."},{"key":"2026011207304154000_16.1.e107535.41","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2023.1178341","article-title":"Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP)","volume":"14","author":"Goodman-Casanova","year":"2023","journal-title":"Front Psychol"},{"key":"2026011207304154000_16.1.e107535.42","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-13-173","article-title":"Effectiveness of structured patient-clinician communication with a solution focused approach (DIALOG+) in community treatment of patients with psychosis--a cluster randomised controlled trial","volume":"13","author":"Priebe","year":"2013","journal-title":"BMC Psychiatry"},{"key":"2026011207304154000_16.1.e107535.43","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291719003155"},{"key":"2026011207304154000_16.1.e107535.44","unstructured":"Kroenke K , Spitzer RL , Williams JBW . The PHQ-9 validity of a brief depression severity measure."},{"key":"2026011207304154000_16.1.e107535.45","unstructured":"Spitzer RL , Kroenke K , Williams JBW , et al . A brief measure for assessing generalized anxiety disorder the GAD-7."},{"key":"2026011207304154000_16.1.e107535.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2003.08.008"},{"key":"2026011207304154000_16.1.e107535.47","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.177.39.s28"},{"key":"2026011207304154000_16.1.e107535.48","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.658"},{"key":"2026011207304154000_16.1.e107535.49","doi-asserted-by":"publisher","DOI":"10.1037\/0735-7028.39.4.435"},{"key":"2026011207304154000_16.1.e107535.50","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081123","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"key":"2026011207304154000_16.1.e107535.51","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081660","article-title":"SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials","volume":"389","author":"Hr\u00f3bjartsson","year":"2025","journal-title":"BMJ"},{"key":"2026011207304154000_16.1.e107535.52","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-018-2733-1","article-title":"Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension","volume":"19","author":"Montgomery","year":"2018","journal-title":"Trials"},{"key":"2026011207304154000_16.1.e107535.53","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2026011207304154000_16.1.e107535.54","unstructured":"Braun V , Clarke V . Thematic Analysis: A Practical Guide. Sage Publications, 2021."},{"key":"2026011207304154000_16.1.e107535.55","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-14-353","article-title":"A process for Decision-making after Pilot and feasibility Trials (ADePT): development following a feasibility study of a complex intervention for pelvic organ prolapse","volume":"14","author":"Bugge","year":"2013","journal-title":"Trials"},{"key":"2026011207304154000_16.1.e107535.56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tics.2018.12.001","article-title":"Hallucinations and Strong Priors","volume":"23","author":"Corlett","year":"2019","journal-title":"Trends Cogn Sci (Regul Ed)"},{"key":"2026011207304154000_16.1.e107535.57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/13546805.2019.1700789","article-title":"Pareidolia-proneness, reality discrimination errors, and visual hallucination-like experiences in a non-clinical sample","volume":"25","author":"Smailes","year":"2020","journal-title":"Cogn Neuropsychiatry"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-107535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:31:57Z","timestamp":1768231917000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-107535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,12]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjopen-2025-107535"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-107535","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}